Elena Provenzano Selected Research

Noninfiltrating Intraductal Carcinoma (DCIS)

2/2022	Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study.
1/2021	Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project.
6/2004	Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena Provenzano Research Topics

Disease

59	Breast Neoplasms (Breast Cancer) 04/2024 - 06/2004
26	Neoplasms (Cancer) 04/2024 - 12/2007
4	Triple Negative Breast Neoplasms 04/2024 - 01/2017
4	Neoplasm Metastasis (Metastasis) 04/2021 - 06/2011
4	Male Breast Neoplasms (Male Breast Cancer) 10/2018 - 06/2012
3	Carcinoma (Carcinomatosis) 03/2024 - 09/2015
3	Hypoxia (Hypoxemia) 09/2023 - 01/2020
3	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2022 - 06/2004
3	Residual Neoplasm 01/2022 - 01/2017
3	Carcinogenesis 07/2015 - 12/2007
2	Cardiotoxicity 01/2020 - 01/2019
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2019 - 01/2017
1	Monosomy 10/2022
1	Confusion (Bewilderment) 04/2021
1	Margins of Excision 01/2021
1	Ductal Carcinoma 01/2020
1	Lobular Carcinoma 01/2020
1	Infections 01/2017
1	Fatigue 01/2017
1	Nausea 01/2017
1	Neutropenia 01/2017
1	Vomiting 01/2017
1	Arthralgia (Joint Pain) 01/2017
1	Myalgia 01/2017
1	Lung Neoplasms (Lung Cancer) 02/2016
1	Ovarian Neoplasms (Ovarian Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2012
7	human ERBB2 proteinIBA 04/2023 - 01/2010
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2007
5	AnthracyclinesIBA 04/2024 - 03/2010
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 03/2010
4	Hormones (Hormone)IBA 01/2022 - 05/2010
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2010
4	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 09/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2024 - 02/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2015
3	Fluorouracil (Carac)FDA LinkGeneric 06/2015 - 03/2010
3	Estrogen ReceptorsIBA 12/2014 - 01/2010
2	fluoromisonidazoleIBA 09/2023 - 01/2021
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2022 - 12/2015
2	Carbon-13IBA 12/2021 - 01/2020
2	Protons (Proton)IBA 12/2021 - 01/2020
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 05/2010
2	Pyruvic Acid (Pyruvate)IBA 01/2020 - 01/2020
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2019
2	ParaffinIBA 01/2018 - 12/2010
2	Phenobarbital (Luminal)FDA Link 01/2018 - 06/2012
2	Formaldehyde (Formol)FDA Link 01/2018 - 12/2010
2	Gemcitabine FDA Link 01/2017 - 02/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2015 - 05/2010
2	Methotrexate (Mexate)FDA LinkGeneric 09/2013 - 03/2010
1	Carboplatin (JM8)FDA LinkGeneric 04/2024
1	olaparibIBA 04/2024
1	Carbonic Anhydrase IXIBA 09/2023
1	trastuzumab deruxtecanIBA 08/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2022
1	Radioisotopes (Radionuclides)IBA 05/2022
1	cyclo(Arg-Pro) (CI 4)IBA 02/2022
1	Immune Checkpoint InhibitorsIBA 12/2021
1	B7-H1 AntigenIBA 12/2021
1	hydrogen sulfite (bisulfite)IBA 01/2021
1	Contrast MediaIBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	Lactate Dehydrogenase 5IBA 01/2020
1	CarbonIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	teleocalcinIBA 10/2018
1	Mediator ComplexIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Eukaryotic Initiation Factor-4EIBA 05/2017
1	Everolimus FDA Link 05/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2017
1	Biological FactorsIBA 01/2017
1	taxaneIBA 01/2017
1	Coloring Agents (Dyes)IBA 12/2015
1	Investigational DrugsIBA 09/2015
1	Annexin A1IBA 07/2015
1	Tumor Biomarkers (Tumor Markers)IBA 07/2015
1	Docetaxel (Taxotere)FDA Link 06/2015
1	Bevacizumab (Avastin)FDA Link 06/2015
1	Keratin-5 (Keratin 5)IBA 01/2015
1	Taxoids (Taxanes)IBA 02/2014
1	1- (ethoxycarbonyloxymethyl)- 5- fluorouracilIBA 09/2013
1	MicroRNAs (MicroRNA)IBA 05/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2013
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2012
1	Hematoxylin (Haematoxylon)IBA 10/2012
1	Protein Isoforms (Isoforms)IBA 06/2012

Therapy/Procedure

15	Neoadjuvant Therapy 04/2024 - 02/2014
13	Therapeutics 08/2023 - 06/2004
10	Drug Therapy (Chemotherapy) 04/2024 - 02/2014
3	Radiotherapy 04/2024 - 01/2017
3	Mastectomy (Mammectomy) 01/2021 - 06/2004
3	Adjuvant Chemotherapy 01/2017 - 03/2010
3	Aftercare (After-Treatment) 01/2017 - 09/2015
2	Immunotherapy 04/2024 - 01/2023
2	Lymph Node Excision (Lymph Node Dissection) 11/2022 - 04/2010
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Breast Implants (Breast Implant) 12/2019